After a tough few weeks for Sarepta Therapeutics Inc., the EMA dealt another blow on July 25, announcing it will not be ...

Sarepta has suffered another regulatory setback after the European Medicines Agency’s (EMA’s) Committee for Medicinal ...

Friday said that the European Medicines Agency has issued a negative opinion on the conditional marketing authorization for Elevidys, intended for ambulatory patients aged three to seven with Duchenne ...

While Sarepta has already suspended both clinical and commercial Elevidys dosing for non-ambulatory patients, the therapy has been mandated by the FDA to carry a black box warning for ALF and ...

Sarepta's stock is jumping Thursday morning after the company announced a restructuring plan. Thomas Fuller / SOPA Images / LightRocket via Getty Images ...

South Sudan's president has called for dialogue amid concerns that the country could relapse into a civil war due to the stalled peace talks, but the opposition had demanded for its members to be ...

JUBA, South Sudan (AP) — South Sudan ’s main opposition party on Thursday dismissed a presidential call for dialogue to avoid the country slipping back into a civil war due to stalled peace talks.

Sarepta agrees to FDA's black box warning and announces major restructuring, including job cuts and cost-saving measures to meet 2027 goals.

Three analysts trimmed their price targets and two hiked theirs in response, with mixed sentiment regarding the positive update but "narrowing" Elevidys market.

The case of Farhad Hoomer has demonstrated South Africa’s difficulties in dealing with homegrown terrorism.